A Randomized Trial of Ustekinumab, a Human Interleukin-12/23 Monoclonal Antibody, in Patients With Moderate-to-Severe Crohn's Disease

William J. Sandborn, Paul Rutgeerts, Richard N. Fedorak et al.|Gastroenterology|2008

Cited by 750